Copper sulfide nanoparticle-based localized drug delivery system as an effective cancer synergistic treatment and theranostic platform

Acta Biomaterialia

Volumn 54, Issue , 2017, Pages 307-320

  Hou, Lin ^a   Shan, Xiaoning ^a   Hao, Lisha ^a   Feng, Qianhua ^a   Zhang, Zhenzhong ^a  

^a ZHENGZHOU UNIVERSITY   (China)

Author keywords

Combination therapy; Diffusion molecular retention; Hollow mesoporous CuS; Localized delivery; Tumor targeted

Indexed keywords

CELLS; CONTROLLED DRUG DELIVERY; CYTOLOGY; DIFFUSION; DISEASES; INFRARED DEVICES; MOLECULAR BIOLOGY; NANOPARTICLES; PHOTOACOUSTIC EFFECT; PHOTODYNAMIC THERAPY; SULFUR COMPOUNDS; TARGETED DRUG DELIVERY; TUMORS;

ARTESUNATE; COMBINATION THERAPY; DIFFUSION MOLECULAR RETENTION; DRUG-DELIVERY SYSTEMS; HOLLOW MESOPOROUS CUS; LOCALISED; LOCALIZED DELIVERY; MESOPOROUS; THERANOSTICS; TUMOR-TARGETED;

COPPER COMPOUNDS;

ARTESUNATE; CONTRAST MEDIUM; COPPER NANOPARTICLE; DRUG CARRIER; HOLLOW MESOPOROUS COPPER SULFIDE NANOPARTICLE; IRON; MESOPOROUS SILICA NANOPARTICLE; REACTIVE OXYGEN METABOLITE; TRANSFERRIN; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; COPPER; NANOPARTICLE; SULFIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CANCER INHIBITION; CANCER RADIOTHERAPY; CANCER THERAPY; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CYTOTOXICITY; DRUG ABSORPTION; DRUG ACCUMULATION; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG EFFICACY; DRUG RETENTION; DRUG TARGETING; ENDOCYTOSIS; FLUORESCENCE IMAGING; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VIVO STUDY; INTERSTITIUM; LASER; MALIGNANT NEOPLASM; MCF-7 CELL LINE; MOUSE; NEAR INFRARED SPECTROSCOPY; NONHUMAN; PERITUMORAL DRUG ADMINISTRATION; PHOTOACOUSTIC TOMOGRAPHY; PHOTOACOUSTICS; PHOTODYNAMIC THERAPY; PHOTOTHERMAL THERAPY; PRIORITY JOURNAL; THERANOSTIC NANOMEDICINE; TRANSMISSION ELECTRON MICROSCOPY; TUMOR CELL; ULTRAVIOLET SPECTROPHOTOMETRY; ANIMAL; CHEMISTRY; DRUG SCREENING; EXPERIMENTAL NEOPLASM; FEMALE; METABOLISM; PATHOLOGY; PROCEDURES;

ANIMALS; ANTINEOPLASTIC AGENTS; CONTRAST MEDIA; COPPER; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; MCF-7 CELLS; MICE; NANOPARTICLES; NEOPLASMS, EXPERIMENTAL; SULFIDES; THERANOSTIC NANOMEDICINE; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 85014846588     PISSN: 17427061     EISSN: 18787568     Source Type: Journal    
DOI: 10.1016/j.actbio.2017.03.005     Document Type: Article

References (40)

1. [1] Luetke, A., Meyers, P.A., Lewis, I., Juergens, H., Osteosarcoma treatment – Where do we stand? A state of the art review. Cancer Treat. Rev. 40 (2014), 523–532.
2. [2] Ma, H.C., He, C.L., Cheng, Y.L., Yang, Z.M., Zang, J.T., Liu, J.G., Chen, X.S., Localized co-delivery of doxorubicin, cisplatin, and methotrexate by thermosensitive hydrogels for enhanced osteosarcoma treatment. ACS Appl. Mater. Inter. 7 (2015), 27040–27048.
3. [3] Lin, Z.Q., Gao, W., Hu, H.X., Ma, K., He, B., Dai, W.B., Wang, X.Q., Wang, J.C., Zhang, X., Zhang, Q., Novel thermo-sensitive hydrogel system with paclitaxel nanocrystals: high drug-loading, sustained drug release and extended local retention guaranteeing better efficacy and lower toxicity. J. Control. Release 174 (2014), 161–170.
4. [4] Kang, Y.M., Kim, G.H., Il Kim, J., Kim, D.Y., Lee, B.N., Yoon, S.M., Kim, J.H., Kim, M.S., In vivo efficacy of an intratumorally injected in situ-forming doxorubicin/poly(ethylene glycol)-b-polycaprolactone diblock copolymer. Biomaterials 32 (2011), 4556–4564.
5. [5] Alexander, A., Ajazuddin, Khan, J., Saraf, S., Saraf, S., Poly(ethylene glycol)–poly(lactic-co-glycolic acid) based thermosensitive injectable hydrogels for biomedical applications. J. Control. Release 172 (2013), 715–729.
6. [6] Wang, W.W., Song, H.J., Zhang, J., Li, P., Li, C., Wang, C., Kong, D.L., Zhang, Q., An injectable, thermosensitive and multicompartment hydrogel for simultaneous encapsulation and independent release of a drug cocktail as an effective combination therapy platform. J. Control. Release 203 (2015), 57–66.
7. [7] Wang, W.W., Deng, L.D., Xu, S.X., Zhao, X.M., Lv, N., Zhang, G.X., Gu, N., Hu, R.J., Zhang, J.H., Liu, J.J., Dong, A.J., A reconstituted “two into one” thermosensitive hydrogel system assembled by drug-loaded amphiphilic copolymer nanoparticles for the local delivery of paclitaxel. J. Mater. Chem. B 1 (2013), 552–563.
8. [8] Nie, S.F., Hsiao, W.L.W., Pan, W.S., Yang, Z.J., Thermoreversible Pluronic (R) F127-based hydrogel containing liposomes for the controlled delivery of paclitaxel: in vitro drug release, cell cytotoxicity, and uptake studies. Int. J. Nanomed. 6 (2011), 151–166.
9. [9] Li, H.J., Du, J.Z., Du, X.J., Xu, C.F., Sun, C.Y., Wang, H.X., Cao, Z.T., Yang, X.Z., Zhu, Y.H., Nie, S.M., Wang, J., Stimuli-responsive clustered nanoparticles for improved tumor penetration and therapeutic efficacy. Proc. Natl. Acad. Sci. USA 113 (2016), 4164–4169.
10. [10] Sanhai, W.R., Sakamoto, J.H., Canady, R., Ferrari, M., Seven challenges for nanomedicine. Nat. Nanotechnol. 3 (2008), 242–244.
11. [11] Guo, Y.Y., Yuan, H.S., Cho, H.S., Kuruppu, D., Jokivarsi, K., Agarwal, A., Shah, K., Josephson, L., High efficiency diffusion molecular retention tumor targeting. PLoS ONE, 8, 2013.
12. [12] Dong, K., Liu, Z., Li, Z.H., Ren, J.S., Qu, X.G., Hydrophobic anticancer drug delivery by a 980 nm laser-driven photothermal vehicle for efficient synergistic therapy of cancer cells in vivo. Adv. Mater. 25 (2013), 4452–4458.
13. [13] Ku, G., Zhou, M., Song, S.L., Huang, Q., Hazle, J., Li, C., Copper sulfide nanoparticles as a new class of photoacoustic contrast agent for deep tissue imaging at 1064 nm. ACS Nano 6 (2012), 7489–7496.
14. [14] Feng, Q., Zhang, Y., Zhang, W., Shan, X., Yuan, Y., Zhang, H., Hou, L., Zhang, Z., Tumor-targeted and multi-stimuli responsive drug delivery system for near-infrared light induced chemo-phototherapy and photoacoustic tomography. Acta Biomater. 38 (2016), 129–142.
15. [15] Wang, S.H., Riedinger, A., Li, H.B., Fu, C.H., Liu, H.Y., Li, L.L., Liu, T.L., Tan, L.F., Barthel, M.J., Pugliese, G., Plasmonic copper sulfide nanocrystals exhibiting near-infrared photothermal and photodynamic therapeutic effects. ACS Nano 9 (2015), 1788–1800.
16. [16] Comin, A., Manna, L., New materials for tunable plasmonic colloidal nanocrystals. Chem. Soc. Rev. 43 (2014), 3957–3975.
17. [17] Chen, T., Chen, R.P., Jin, Z., Liu, J., Engineering hollow mesoporous silica nanocontainers with molecular switches for continuous self-healing anticorrosion coating. J. Mater. Chem. A 3 (2015), 9510–9516.
18. [18] Li, J.L., Wang, L., Liu, X.Y., Zhang, Z.P., Guo, H.C., Liu, W.M., Tang, S.H., In vitro cancer cell imaging and therapy using transferrin-conjugated gold nanoparticles. Cancer Lett. 274 (2009), 319–326.
19. [19] Yang, Y., Zhang, X.M., Wang, X.F., Zhao, X.M., Ren, T.R., Wang, F., Yu, B., Enhanced delivery of artemisinin and its analogues to cancer cells by their adducts with human serum transferrin. Int. J. Pharmaceut. 467 (2014), 113–122.
20. [20] Oh, S., Kim, B.J., Singh, N.P., Lai, H., Sasaki, T., Synthesis and anti-cancer activity of covalent conjugates of artemisinin and a transferrin-receptor targeting peptide. Cancer Lett. 274 (2009), 33–39.
21. [21] Zhang, H.J., Hou, L., Jiao, X.J., Ji, Y.D., Zhu, X.L., Zhang, Z.Z., Transferrin-mediated fullerenes nanoparticles as Fe2+-dependent drug vehicles for synergistic anti-tumor efficacy. Biomaterials 37 (2015), 353–366.
22. [22] Mou, J., Li, P., Liu, C.B., Xu, H.X., Song, L., Wang, J., Zhang, K., Chen, Y., Shi, J.L., Chen, H.R., Ultrasmall Cu2-xS nanodots for highly efficient photoacoustic imaging-guided photothermal therapy. Small 11 (2015), 2275–2283.
23. [23] Liu, X., Swihart, M.T., Heavily-doped colloidal semiconductor and metal oxide nanocrystals: an emerging new class of plasmonic nanomaterials. Chem. Soc. Rev. 43 (2014), 3908–3920.
24. [24] Bajaj, G., Yeo, Y., Hyaluronic acid-based hydrogel for regional delivery of paclitaxel to intraperitoneal tumors (vol 158, pg 386, 2012). J. Control. Release, 162, 2012, 257.
25. [25] Chen, F., Hong, H., Goel, S., Graves, S.A., Orbay, H., Ehlerding, E.B., Shi, S.X., Theuer, C.P., Nickles, R.J., Cai, W.B., In vivo tumor vasculature targeting of CuS@MSN based theranostic nanomedicine. ACS Nano 9 (2015), 3926–3934.
26. [26] Huang, Y.Z., Lai, Y.L., Shi, S.G., Hao, S.F., Wei, J.P., Chen, X.L., Copper sulfide nanoparticles with phospholipid-PEG coating for in vivo near-infrared photothermal cancer therapy. Chem-Asian J. 10 (2015), 370–376.
27. [27] Yan, L., Chang, Y.-N., Zhao, L., Gu, Z., Liu, X., Tian, G., Zhou, L., Ren, W., Jin, S., Yin, W., The use of polyethylenimine-modified graphene oxide as a nanocarrier for transferring hydrophobic nanocrystals into water to produce water-dispersible hybrids for use in drug delivery. Carbon 57 (2013), 120–129.
28. [28] Zeng, X., Morgenstern, R., Nystrom, A.M., Nanoparticle-directed sub-cellular localization of doxorubicin and the sensitization breast cancer cells by circumventing GST-mediated drug resistance. Biomaterials 35 (2014), 1227–1239.
29. [29] Yang, K., Zhu, L., Nie, L., Sun, X., Cheng, L., Wu, C., Niu, G., Chen, X., Liu, Z., Visualization of protease activity in vivo using an activatable photo-acoustic imaging probe based on CuS nanoparticles. Theranostics 4 (2014), 134–141.
30. [30] Crespo-Ortiz, M.P., Wei, M.Q., Antitumor activity of artemisinin and its derivatives: from a well-known antimalarial agent to a potential anticancer drug. J. Biomed. Biotechnol., 2012, 2012, 247597.
31. [31] Nakase, I., Gallis, B., Takatani-Nakase, T., Oh, S., Lacoste, E., Singh, N.P., Goodlett, D.R., Tanaka, S., Futaki, S., Lai, H., Transferrin receptor-dependent cytotoxicity of artemisinin-transferrin conjugates on prostate cancer cells and induction of apoptosis. Cancer Lett. 274 (2009), 290–298.
32. [32] Ba, Q., Zhou, N., Duan, J., Chen, T., Hao, M., Yang, X., Li, J., Yin, J., Chu, R., Wang, H., Dihydroartemisinin exerts its anticancer activity through depleting cellular iron via transferrin receptor-1. PLoS ONE, 7, 2012, e42703.
33. [33] Galal, A.M., Ross, S.A., ElSohly, M.A., ElSohly, H.N., El-Feraly, F.S., Ahmed, M.S., McPhail, A.T., Deoxyartemisinin derivatives from photooxygenation of anhydrodeoxydihydroartemisinin and their cytotoxic evaluation. J. Nat. Prod. 65 (2002), 184–188.
34. [34] Lai, H., Sasaki, T., Singh, N.P., Messay, A., Effects of artemisinin-tagged holotransferrin on cancer cells. Life Sci. 76 (2005), 1267–1279.
35. [35] Hamacher-Brady, A., Stein, H.A., Turschner, S., Toegel, I., Mora, R., Jennewein, N., Efferth, T., Eils, R., Brady, N.R., Artesunate activates mitochondrial apoptosis in breast cancer cells via iron-catalyzed lysosomal reactive oxygen species production. J. Biol. Chem. 286 (2011), 6587–6601.
36. [36] Mercer, A.E., Copple, I.M., Maggs, J.L., O'Neill, P.M., Park, B.K., The role of heme and the mitochondrion in the chemical and molecular mechanisms of mammalian cell death induced by the artemisinin antimalarials. J. Biol. Chem. 286 (2011), 987–996.
37. [37] Safavy, A., Recent developments in taxane drug delivery. Curr. Drug Deliv. 5 (2008), 42–54.
38. [38] Bae, Y.H., Park, K., Targeted drug delivery to tumors: myths, reality and possibility. J. Control. Release 153 (2011), 198–205.
39. [39] Efferth, T., Benakis, A., Romero, M.R., Tomicic, M., Rauh, R., Steinbach, D., Hafer, R., Stamminger, T., Oesch, F., Kaina, B., Marschall, M., Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron. Free Radical Biol. Med. 37 (2004), 998–1009.
40. [40] Hou, L., Yao, J., Zhou, J., Zhang, Q., Pharmacokinetics of a paclitaxel-loaded low molecular weight heparin-all-trans-retinoid acid conjugate ternary nanoparticulate drug delivery system. Biomaterials 33 (2012), 5431–5440.